Advertisement
Screener

Foghorn Therapeutics Inc. (FHTX) Finance Lease, Liability, Current

2.8 / 5 stars · 68/120 Roast Me

Foghorn Therapeutics Inc. Finance Lease, Liability, Current

Foghorn Therapeutics Inc. (FHTX) had Finance Lease, Liability, Current of $106.00 thousand as of 2021-06-30, per its 10-Q filed 2021-08-10.

Discontinued › Balance Sheet › Liabilities › Long-Term Debt and Lease Obligation, Current

us-gaap:FinanceLeaseLiabilityCurrent · last filed 2021-08-10

  • 2021-06-30: Finance Lease, Liability, Current $106.00K.
  • 2021-03-31: Finance Lease, Liability, Current $105.00K.
  • 2020-12-31: Finance Lease, Liability, Current $0.00.
Period endFinance Lease, Liability, Current
2021-06-30$106.00K
10-Q · filed 2021-08-10
2021-03-31$105.00K
10-Q · filed 2021-05-11
2020-12-31$0.00
10-Q · filed 2021-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Nkarta, Inc. (NKTX)United States$0.205B-1.73
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37